GlassScriptPhysician profile
Jill S Lindberg
NPI 1952393795
$28,297.80
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $2,559.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $25,246.17 | 2019 | |
| Opko Pharmaceuticals, LLC | $2,468.78 | 2019-2020 | |
| Amgen INC. | $153.19 | 2019-2020 | |
| Akebia Therapeutics INC | $133.42 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $92.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $54.24 | 2019 | |
| Vifor Pharma, INC. | $34.18 | 2020 | |
| Radius Health, INC. | $33.70 | 2019 | |
| Travere Therapeutics, INC. | $20.89 | 2019 | |
| Hikma Pharmaceuticals USA | $20.10 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.64 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.77 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Lindberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.